HUP0101931A2 - Paroxetint tartalmazó új készítmény - Google Patents

Paroxetint tartalmazó új készítmény

Info

Publication number
HUP0101931A2
HUP0101931A2 HU0101931A HUP0101931A HUP0101931A2 HU P0101931 A2 HUP0101931 A2 HU P0101931A2 HU 0101931 A HU0101931 A HU 0101931A HU P0101931 A HUP0101931 A HU P0101931A HU P0101931 A2 HUP0101931 A2 HU P0101931A2
Authority
HU
Hungary
Prior art keywords
hemihydrate
conditions
formulation containing
novel formulation
detectable
Prior art date
Application number
HU0101931A
Other languages
English (en)
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0101931A2 publication Critical patent/HUP0101931A2/hu
Publication of HUP0101931A3 publication Critical patent/HUP0101931A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

A tal lm ny egy, a hemihidr ttól eltérő form ban lévő paroxetin-hidrokloridra vonatkozik, amelyet olyan k"rülmények k"z"tt form lnakkapszul kba, amely k"rülmények k"z"tt az elő llít si elj r s sor nnincs detekt lható mértékű hemihidr tt t"rténő talakul s. A tal lm nyt rgy t képezi tov bb egy elj r s detekt lható hemihidr ttól mentesparoxetin-hidroklorid-anhidr t kapszul k elő llít s ra, amelynek sor nolyan k"rülményeket alkalmaznak, amely k"rülmények k"z"tt az elő llítsi elj r s sor n nem lép fel detekt lható mértékű anhidr tból hemihidrtt t"rténő talakul s. Ilyen k"rülményeket úgy biztosítanak, hogyalacsony relatív p ratartalom mellett lényegében vízmentes és/vagyhidrofób vivőanyagokat alkalmaznak. Ó
HU0101931A 1998-05-13 1999-05-13 Novel formulation containing paroxetine HUP0101931A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
HUP0101931A2 true HUP0101931A2 (hu) 2002-04-29
HUP0101931A3 HUP0101931A3 (en) 2002-10-28

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101931A HUP0101931A3 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077685A2 (hu)
JP (1) JP2002514593A (hu)
KR (1) KR20010043545A (hu)
CN (1) CN1309557A (hu)
AP (1) AP2000001985A0 (hu)
AU (1) AU3941099A (hu)
BG (1) BG105011A (hu)
BR (1) BR9910402A (hu)
CA (1) CA2331849A1 (hu)
EA (1) EA200001173A1 (hu)
GB (1) GB9810180D0 (hu)
HU (1) HUP0101931A3 (hu)
ID (1) ID27018A (hu)
IL (1) IL139596A0 (hu)
NO (1) NO20005681L (hu)
PL (1) PL344872A1 (hu)
SK (1) SK16972000A3 (hu)
TR (1) TR200003351T2 (hu)
WO (1) WO1999058116A2 (hu)
ZA (1) ZA200006465B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
PL344872A1 (en) 2001-11-19
NO20005681L (no) 2000-12-01
NO20005681D0 (no) 2000-11-10
WO1999058116A3 (en) 2000-02-17
AU3941099A (en) 1999-11-29
JP2002514593A (ja) 2002-05-21
KR20010043545A (ko) 2001-05-25
CA2331849A1 (en) 1999-11-18
ZA200006465B (en) 2001-11-09
BR9910402A (pt) 2001-01-09
IL139596A0 (en) 2002-02-10
EP1077685A2 (en) 2001-02-28
HUP0101931A3 (en) 2002-10-28
GB9810180D0 (en) 1998-07-08
BG105011A (en) 2001-07-31
WO1999058116A2 (en) 1999-11-18
CN1309557A (zh) 2001-08-22
TR200003351T2 (tr) 2001-03-21
EA200001173A1 (ru) 2001-04-23
AP2000001985A0 (en) 2000-12-31
ID27018A (id) 2001-02-22
SK16972000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
MXPA02011900A (es) Composicion fotosensible para fabricacion de fotorresistente.
HUP0302284A2 (hu) Egy triazolo[4,5-d]pirimidin-vegyület új kristályos és amorf formái
ATE328851T1 (de) Magnesium-ammonium-phosphat-zemente, deren herstellung und verwendung
ATE516062T1 (de) Quaternäre ammoniumverbindungen enthaltende wasserfreie zusammensetzungen
HK1034909A1 (en) Novel fatty analogues for the treatment of diabetes
HUP0203821A2 (hu) Új oligoszacharidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
CA2341466A1 (en) Gypsum wallboard, and method of making same
HUP0203064A2 (en) Granules based on starch and lactose
HUP0003056A2 (hu) Fogeróziót csökkentő szilárd készítmény
NO176549C (no) Fremgangsmåte for fremstilling av L-dopa-kjerner med 2 overtrekk
WO2003014080A3 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
HUP0301766A2 (hu) Latens antitrombin III előállítása
HUP0101931A2 (hu) Paroxetint tartalmazó új készítmény
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
ZA952771B (en) Novel compound
HUP0300856A2 (hu) Eljárás szubsztituált fenil-acetonitrilek elżállítására
MX9709652A (es) Metodo para preparar ureas ciclicas asimetricas n-monsustituidas y n,n'-disustituidas.
NO20004919D0 (no) FremgangsmÕte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
HUP0100333A2 (hu) Tartósítószer rendszer testápolószer számára
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
EP0169710A3 (en) 7-substituted-6-fluoro-8-substituted-1,4-dihydro-1-methylamino-4-oxo-3-quinolinecarboxylic acids; 7-substituted-6-fluoro-1,4-dihydro-1-methylamino-4-oxo-3-naphthyridine carboxylic acids; derivatives thereof; and processes for producing the compounds
WO2003020209A3 (en) Processes for the production of alpha-difluoromethyl ornithine (dfmo)
PL366988A1 (en) Gelling sugar and method for producing the same
BG103674A (en) Polymorphous form of zopolrestatmonohydrate
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.